Both in Pharmaceuticals
Summit Therapeutics vs Elanco Animal Health Incorporated
Over the past year SMMT returned −7.5% and ELAN returned +12.5%; their daily moves had a correlation of 0.17.
SMMT −7.5% ELAN +12.5%Growth of $1, one year, split-adjusted
| Metric | SMMT | ELAN |
|---|---|---|
| Price | $16.17 | $25.31 |
| Market cap | $12.90B | $12.65B |
| Today | +2.34% | +3.01% |
| 1 month | −6.6% | +12.6% |
| 6 months | −9.4% | −3.3% |
| Year to date | −7.5% | +11.8% |
| 1 year | −11.3% | +10.8% |
| Revenue growth (YoY) | — | +10.2% |
| Gross margin | — | 58.3% |
| Net margin | — | 3.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.5× |
| Net cash | $690.7M | -$3.39B |
| Dividend yield | — | — |
| Volatility (60d) | 70.7% | 30.7% |
| Short % of float | 29.5% | 6.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).